Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Goodwill & Intangibles: 2021-2025

Historic Goodwill & Intangibles for BridgeBio Pharma (BBIO) over the last 5 years, with Sep 2025 value amounting to $28.8 million.

  • BridgeBio Pharma's Goodwill & Intangibles rose 17.41% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 17.41%. This contributed to the annual value of $23.9 million for FY2024, which is 9.09% down from last year.
  • According to the latest figures from Q3 2025, BridgeBio Pharma's Goodwill & Intangibles is $28.8 million, which was down 2.43% from $29.5 million recorded in Q2 2025.
  • BridgeBio Pharma's Goodwill & Intangibles' 5-year high stood at $46.2 million during Q3 2021, with a 5-year trough of $20.0 million in Q2 2021.
  • Its 3-year average for Goodwill & Intangibles is $26.8 million, with a median of $26.9 million in 2023.
  • Over the last 5 years, BridgeBio Pharma's Goodwill & Intangibles had its largest YoY gain of 49.54% in 2022, and its largest YoY loss of 36.56% in 2022.
  • Quarterly analysis of 5 years shows BridgeBio Pharma's Goodwill & Intangibles stood at $44.9 million in 2021, then plummeted by 36.10% to $28.7 million in 2022, then dropped by 8.33% to $26.3 million in 2023, then fell by 9.09% to $23.9 million in 2024, then increased by 17.41% to $28.8 million in 2025.
  • Its Goodwill & Intangibles stands at $28.8 million for Q3 2025, versus $29.5 million for Q2 2025 and $27.8 million for Q1 2025.